The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children
Open accessAbstract
OBJECTIVES: Previously, web-based tools for cross-sectional antimicrobial point prevalence surveys (PPSs) have been used in adults to develop indicators of quality improvement. We aimed to determine the feasibility of developing similar quality indicators of improved antimicrobial prescribing focusing specifically on hospitalized neonates and children worldwide. METHODS: A standardized antimicrobial PPS method was employed. Included were all inpatient children and neonates receiving an antimicrobial at 8:00 am on the day of the PPS. Denominators included the total number of inpatients. A web-based application was used for data entry, validation and reporting. We analysed 2012 data from 226 hospitals (H) in 41 countries (C) from Europe (174H; 24C), Africa (6H; 4C), Asia (25H; 8C), Australia (6H), Latin America (11H; 3C) and North America (4H). RESULTS: Of 17,693 admissions, 6499 (36.7%) inpatients received at least one antimicrobial, but this varied considerably between wards and regions. Potential indicators included very high broad-spectrum antibiotic prescribing in children of mainly ceftriaxone (ranked first in Eastern Europe, 31.3%; Asia, 13.0%; Southern Europe, 9.8%), cefepime (ranked third in North America, 7.8%) and meropenem (ranked first in Latin America, 13.1%). The survey identified worryingly high use of critically important antibiotics for hospital-acquired infections in neonates (34.9%; range from 14.2% in Africa to 68.0% in Latin America) compared with children (28.3%; range from 14.5% in Africa to 48.9% in Latin America). Parenteral administration was very common among children in Asia (88%), Latin America (81%) and Europe (67%). Documentation of the reasons for antibiotic prescribing was lowest in Latin America (52%). Prolonged surgical prophylaxis rates ranged from 78% (Europe) to 84% (Latin America). CONCLUSIONS: Simple web-based PPS tools provide a feasible method to identify areas for improvement of antibiotic use, to set benchmarks and to monitor future interventions in hospitalized neonates and children. To our knowledge, this study has derived the first global quality indicators for antibiotic use in hospitalized neonates and children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
United Nations Statistics Division
(2006) · Choice Reviews Online · doi:10.5860/choice.43sup-0473 · Cited by 1,202
Zarb, P., Coignard, B., Griskeviciene, J., Muller, A., Vankerckhoven, V, Weist, K., Goossens, M. M., Vaerenberg, S., Hopkins, S., Catry, B., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.46.20316-en · Cited by 785
Self-citation(2010) · Choice Reviews Online · doi:10.5860/choice.47-2356 · Cited by 390
Antibiotic consumption and link to resistance
Goossens, H. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02725.x · Cited by 379
Self-citationFormulation of medicines for children
Nunn, T., & Williams, J. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02410.x · Cited by 272
High burden of antimicrobial resistance in Asia
Jean, S.-S., & Hsueh, P.-R. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.009 · Cited by 249
Switch over from intravenous to oral therapy: A concise overview
Cyriac, J. M., & James, E. (2014) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.130042 · Cited by 247
Ansari, F., Erntell, M., Goossens, H., & Davey, P. (2009) · Clinical Infectious Diseases · doi:10.1086/644617 · Cited by 233
Self-citationZhang, L., Huang, Y., Zhou, Y., Buckley, T., & Wang, H. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00670-13 · Cited by 212
Sevinc, F., Prins, J. M., Koopmans, R. P., Langendijk, P. N. J., Bossuyt, P. M., Dankert, J., & Speelman, P. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.601 · Cited by 172
Cited by
Versporten, A., Zarb, P., Caniaux, I., Gros, M.-F., Drapier, N., Miller, M., Jarlier, V., Nathwani, D., Goossens, H., Koraqi, A., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30186-4 · Cited by 671
Self-citationHsia, Y., Lee, B. R., Versporten, A., Yang, Y., Bielicki, J., Jackson, C., Newland, J., Goossens, H., Magrini, N., Sharland, M., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30071-3 · Cited by 350
Self-citationDonà, D., Barbieri, E., Daverio, M., Lundin, R., Giaquinto, C., Zaoutis, T., & Sharland, M. (2020) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0659-3 · Cited by 199
Self-citation
Metadata
- Authors
- Versporten, A., Bielicki, J., Drapier, N., Sharland, M., & Goossens, H.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-01-08
- Volume
- 71
- Issue
- 4
- Pages
- 1106-1117
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2227678480
- Cited by
- 312
- References
- 20
- FWCI
- 19.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. https://app.cochat.ai/papers/10.1093/jac/dkv418
- The paper
- Versporten, A., Bielicki, J., Drapier, N., Sharland, M., & Goossens, H. (2016). The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkv418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.